![Doron Sagman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Doron Sagman served as the Senior Medical Director and VP-Research & Development at Eli Lilly Canada, Inc. He also worked as the Chief Medical Officer at Mind Cure Health, Inc. in 2021-2022.
Sagman holds a doctorate degree from the University of Calgary.
| Unternehmen | Position | Ende |
|---|---|---|
| LNG ENERGY GROUP CORP. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 |
Eli Lilly Canada, Inc.
 Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Health Technology |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mind Cure Health, Inc.
 Mind Cure Health, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures, and distributes branded organic functional mushroom powder | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
